Aeterna’s AEZS-108 final Phase 2 outcomes in endometrial malignancy to be presented at ESGO 2011 Aeterna Zentaris Inc. The trial was conducted by the German AGO Study Group and research centers in Bulgaria. AEZS-108, a targeted cytotoxic peptide conjugate, happens to be in Phase 1/2 applications in prostate and bladder cancers, and has successfully completed Stage 2 trials in endometrial and ovarian cancer.ADP’s $500,000 donation can help Feeding America offer 4 approximately.5 million pounds of food and grocery items to low-income Americans. Our food banks continue to offer with record amounts of those who are desperately looking for help to feed their families, said Vicki Escarra, president and chief executive officer of Feeding America. We’d end up being overwhelmed without the generous support of companions like ADP. Across the board, food banks are witnessing an average increased need of almost 20 %. Some food banking institutions are even reporting they are now providing emergency food to people who had been once donors.